These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1361206)

  • 21. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
    Chang PC; van Veen S; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemodynamic, metabolic, and lymphocyte beta 2-adrenoceptor changes following chronic beta-adrenoceptor antagonism.
    Whyte K; Jones CR; Howie CA; Deighton N; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1987; 32(3):237-43. PubMed ID: 2885202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships between acute and chronic beta-blocking effects of bisoprolol in healthy volunteers: a practical approach to predict intensity of beta-blockade.
    Jamin P; LeCoz F; Funck-Brentano C; Poirier JM; Jaillon P
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):658-63. PubMed ID: 7516019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?
    Rolf Smith S; Kendall MJ; Worthington DJ; Holder R
    Br J Clin Pharmacol; 1983 Nov; 16(5):557-60. PubMed ID: 6139123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selectivity of antagonist and partial agonist activity of celiprolol in normal subjects.
    Wheeldon NM; McDevitt DG; Lipworth BJ
    Br J Clin Pharmacol; 1992 Oct; 34(4):337-43. PubMed ID: 1333781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concentration kinetics of propranolol, bisoprolol, and atenolol in humans assessed with chemical detection and a subtype-selective beta-adrenoceptor assay.
    Wellstein A; Palm D; Belz GG; Leopold G; Bühring KU; Pabst J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S41-5. PubMed ID: 2439797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.
    Lipworth BJ; McFarlane LC; Coutie WJ; McDevitt DG
    Eur J Clin Pharmacol; 1989; 37(3):297-300. PubMed ID: 2575521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral pharmacokinetics of bisoprolol in resting and exercising healthy volunteers.
    Le Coz F; Sauleman P; Poirier JM; Cuche JL; Midavaine M; Rames A; Lecocq B; Jaillon P
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):28-34. PubMed ID: 1719288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effects of bisoprolol and acebutolol in smokers with airway obstruction.
    Macquin-Mavier I; Roudot-Thoraval F; Clerici C; George C; Harf A
    Br J Clin Pharmacol; 1988 Sep; 26(3):279-84. PubMed ID: 2902873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Mar; 45(3):271-6. PubMed ID: 9517371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pretreatment with the selective beta 1-adrenoceptor antagonist bisoprolol on the subsequent cardiovascular actions and beta-adrenoceptor subtype specific occupancy of celiprolol in healthy man.
    de Mey C; Beithaupt K; Palm D; Fuhr U; Belz GG
    Eur J Clin Pharmacol; 1993; 44(4):341-8. PubMed ID: 8390369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bisoprolol-based
    Kang J; More KN; Pyo A; Jung Y; Kim DY; Chang DJ
    Bioorg Med Chem Lett; 2021 Mar; 36():127789. PubMed ID: 33453362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of Bisoprolol on Heart Rate Variability in Patients With Coronary Atherosclerosis: Dependence on Polymorphisms of -1 Adrenergic Receptor Gene].
    Bunova SS; Zamakhina OV; Usacheva EV; Nelidova AV; Voronina EN
    Kardiologiia; 2017 Mar; 57(3):20-24. PubMed ID: 28762931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric synthesis and preliminary evaluation of (R)- and (S)-[11C]bisoprolol, a putative beta1-selective adrenoceptor radioligand.
    Soloviev DV; Matarrese M; Moresco RM; Todde S; Bonasera TA; Sudati F; Simonelli P; Magni F; Colombo D; Carpinelli A; Kienle MG; Fazio F
    Neurochem Int; 2001 Feb; 38(2):169-80. PubMed ID: 11137886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beta1-adrenoceptor mediated origin of the heart rate performance curve deflection.
    Hofmann P; Wonisch M; Pokan R; Schwaberger G; Smekal G; von Duvillard SP
    Med Sci Sports Exerc; 2005 Oct; 37(10):1704-9. PubMed ID: 16260969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of bisoprolol, a selective beta1-blocker, on glucose metabolism by long-term administration in essential hypertension.
    Owada A; Suda S; Hata T; Miyake S
    Clin Exp Hypertens; 2001 May; 23(4):305-16. PubMed ID: 11349822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and pharmacodynamics of bisoprolol in rats with bilateral ureter ligation-induced renal failure.
    Tahara K; Saigusa K; Kagawa Y; Taguchi M; Hashimoto Y
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):389-94. PubMed ID: 17072092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac beta 2-adrenoceptor stimulation in humans.
    Hall JA
    J Am Coll Cardiol; 1994 Nov; 24(5):1428-9. PubMed ID: 7930270
    [No Abstract]   [Full Text] [Related]  

  • 40. The relationship between cardiovascular reactivity in the laboratory and heart rate response in real life: active coping and beta blockade.
    Johnston DW; Schmidt TF; Albus C; Vagt S; McSorley K; Klingmann I; Bethge H
    Psychosom Med; 1994; 56(4):369-76. PubMed ID: 7972620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.